Nanobac Long Term Debt vs Preferred Stock Total Equity Analysis
| NNBP Stock | USD 0.0001 0.00 0.00% |
Nanobac Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Nanobac Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nanobac Pharmaceuticals is a good investment. Please check the relationship between Nanobac Pharmaceuticals Long Term Debt and its Preferred Stock Total Equity accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Long Term Debt vs Preferred Stock Total Equity
Long Term Debt vs Preferred Stock Total Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nanobac Pharmaceuticals Long Term Debt account and Preferred Stock Total Equity. At this time, the significance of the direction appears to have totally related.
The correlation between Nanobac Pharmaceuticals' Long Term Debt and Preferred Stock Total Equity is 1.0. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Preferred Stock Total Equity in the same time period over historical financial statements of Nanobac Pharmaceuticals Incorporated, assuming nothing else is changed. The correlation between historical values of Nanobac Pharmaceuticals' Long Term Debt and Preferred Stock Total Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Nanobac Pharmaceuticals Incorporated are associated (or correlated) with its Preferred Stock Total Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Preferred Stock Total Equity has no effect on the direction of Long Term Debt i.e., Nanobac Pharmaceuticals' Long Term Debt and Preferred Stock Total Equity go up and down completely randomly.
Correlation Coefficient | 1.0 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Long Term Debt
Long-term debt is a debt that Nanobac Pharmaceuticals has held for over one year. Long-term debt appears on Nanobac Pharmaceuticals Incorporated balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Nanobac Pharmaceuticals Incorporated balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.Preferred Stock Total Equity
Most indicators from Nanobac Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nanobac Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. As of 11/30/2024, Selling General Administrative is likely to drop to about 2.6 M. In addition to that, Discontinued Operations is likely to drop to about (54.1 K)
| 2010 | 2011 | 2023 | 2024 (projected) | Gross Profit | 8K | 3.1K | 3.6K | 3.4K | Total Revenue | 12K | 17.6K | 15.9K | 15.1K |
Nanobac Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Nanobac Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Additional Tools for Nanobac Stock Analysis
When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.